CD4 and neoplasm: Since cognate interactions between helper CD4+ T cells and B cells are required to produce the tumor-specific isotype switched B cells and antibodies detected in many cancer patients [3], the consequences of such interactions are of relevance to our rapidly growing understanding of the anti-tumor immune response.